enVVeno Medical (NASDAQ:NVNO) Releases Earnings Results, Beats Estimates By $0.05 EPS

enVVeno Medical (NASDAQ:NVNO) issued its earnings results on Thursday. The company reported ($0.30) EPS for the quarter, topping analysts’ consensus estimates of ($0.35) by $0.05, Zacks reports.

enVVeno Medical Price Performance

Shares of NASDAQ:NVNO traded down $0.35 during trading on Friday, reaching $3.18. 239,342 shares of the company were exchanged, compared to its average volume of 111,170. The firm has a market capitalization of $55.76 million, a PE ratio of -2.47 and a beta of 1.22. The business’s fifty day simple moving average is $3.27 and its 200-day simple moving average is $3.70. enVVeno Medical has a 12-month low of $2.45 and a 12-month high of $6.97.

About enVVeno Medical

enVVeno Medical Corporation (Nasdaq: NVNO) is an medical device company focused on the development of innovative bioprosthetic (tissue-based) devices to improve the standard of care in the treatment of venous disease. The company’s lead product, the VenoValve®️, is a first-in-class, surgical implant being developed for the treatment of severe deep venous Chronic Venous Insufficiency (CVI).